Earnings FeedTerminal

⌘K

Home/Companies/JANX

J

JANX//CIK 0001817713

Janux Therapeutics, Inc.

SIC 2834Pharmaceutical Preparationsoperating

Add to watchlist

Exchange

Nasdaq

Entity type

operating

Fiscal year end

Dec 31

Headquarters

DE

Market Data

Dec 5, 9:30 AM ET

$16.51−$11.03 (−40.05%)

JANX · Last trade

Prev Close

$27.54

Range (29d)

$15.86 – $34.74

Recent Filings

5 items

SC 13D/A
Janux Therapeutics, Inc.
Jun 5, 7:28 PM ET·0001104659-24-068766
253.6 KB
SC 13G
Janux Therapeutics, Inc.
Jan 20, 5:32 PM ET·0000935836-23-000053
47.1 KB
SC 13D/A
Janux Therapeutics, Inc.
Dec 17, 5:08 PM ET·0000947871-21-001298
140.6 KB
SC 13G
Janux Therapeutics, Inc.
Jun 25, 6:08 AM ET·0001193125-21-199391
40.9 KB
SC 13D
Janux Therapeutics, Inc.
Jun 25, 6:07 AM ET·0001193125-21-199387
239.6 KB

Insiders

5

Tickers

JANXNasdaq→

Addresses

business
10955 VISTA SORRENTO PARKWAY SUITE 200
SAN DIEGO, CA, 92130
mailing
10955 VISTA SORRENTO PARKWAY SUITE 200
SAN DIEGO, CA, 92130

Related Pharmaceutical Preparations Companies

GENELABS TECHNOLOGIES INC /CA

VICURON PHARMACEUTICALS INC

METABASIS THERAPEUTICS INC

NeurogesX Inc

DiaMedica Therapeutics Inc.

DMAC

Milestone Pharmaceuticals Inc.

MIST

Aimmune Therapeutics, Inc.

View all Pharmaceutical Preparations companies →